Correlation between antibiotic use in childhood and subsequent inflammatory bowel disease: a systematic review and meta-analysis

References

• Sairenji T, Collins KL, Evans DV. An update on inflammatory bowel disease. Prim Care Clin off Pract. 2017;44:673–692.
   PubMed Web of Science ®Google Scholar
• Castiglione F, Diaferia M, Morace F, et al. Risk factors for inflammatory bowel diseases according to the “hygiene hypothesis”: a case-control, multi-centre, prospective study in Southern Italy. J Crohn’s Colitis. 2012;6:324–329.
   Google Scholar
• Theochari NA, Stefanopoulos A, Mylonas KS, et al. Antibiotics exposure and risk of inflammatory bowel disease: a systematic review. Scand J Gastroenterol. 2018;53:1–7.
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015;12:205–217.
   PubMed Web of Science ®Google Scholar
• Karban A, Eliakim R. Effect of smoking on inflammatory bowel disease: is it disease or organ specific? WJG. 2007;13:2150–2152.
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Shanahan F. Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut. 2008;57:1185–1191.
   PubMed Web of Science ®Google Scholar
• Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA. 2008;105:16731–16736.
   PubMed Web of Science ®Google Scholar
• Leong RW, Mitrev N, Ko Y. Hygiene hypothesis: is the evidence the same all over the world? Dig Dis. 2016;34:35–42.
   PubMed Web of Science ®Google Scholar
• Kotlowski R, Bernstein CN, Sepehri S, et al. High prevalence of Escherichia coli belonging to the B2 + D phylogenetic group in inflammatory bowel disease. Gut. 2007;56:669–675.
   PubMed Web of Science ®Google Scholar
• Tannock GW. The search for disease-associated compositional shifts in bowel bacterial communities of humans. Trends Microbiol. 2008;16:488–495.
   PubMed Web of Science ®Google Scholar
• Hviid A, Svanström H, Frisch M. Antibiotic use and inflammatory bowel diseases in childhood. Gut. 2011;60:49–54.
   PubMed Web of Science ®Google Scholar
• Penders J, Thijs C, Vink C, et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics. 2006;118:511–521.
   PubMed Web of Science ®Google Scholar
• Bernstein CN. Antibiotics, probiotics and prebiotics in IBD. Nestle Nutr Inst Workshop Ser. 2014;79:83–100.
   PubMedGoogle Scholar
• Ng SC, Tang W, Leong RW, et al. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut. 2015;64:1063–1071.
   PubMed Web of Science ®Google Scholar
• Song C, Yang J, Ye W, et al. Urban–rural environmental exposure during childhood and subsequent risk of inflammatory bowel disease: a meta-analysis. Expert Rev Gastroenterol Hepatol. 2019;13:591–602.
   PubMed Web of Science ®Google Scholar
• Virta L, Auvinen A, Helenius H, et al. Association of repeated exposure to antibiotics with the development of pediatric Crohn’s disease – a nationwide, register-based Finnish case-control study. Am J Epidemiol. 2012;175:775–784.
   PubMed Web of Science ®Google Scholar
• Han DY, Fraser AG, Dryland P, et al. Environmental factors in the development of chronic inflammation: a case-control study on risk factors for Crohn’s disease within New Zealand. Mutat Res - Fundam Mol Mech Mutagen. 2010;690:116–122.
   PubMed Web of Science ®Google Scholar
• Troelsen FS, Jick S. Antibiotic use in childhood and adolescence and risk of inflammatory bowel disease: a case–control study in the UK clinical practice research datalink. Inflamm Bowel Dis. 2020;26:440–447.
   PubMed Web of Science ®Google Scholar
• Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am J Gastroenterol. 2010;105:2687–2692.
   PubMed Web of Science ®Google Scholar
• Shaw SY, Blanchard J, Bernstein CN. 95 Antibiotic prescriptions in the first year of life increases the risk of pediatric inflammatory bowel disease: a population-based analysis. Gastroenterology. 2010;138:S-17.
   Web of Science ®Google Scholar
• Almasri J, Murad M, King KS, et al. Tu1871 – The association between antibiotics exposure during the peripartum period and the risk of developing autoimmune and autistic spectrum disorders. Gastroenterology. 2019;156:S-1153.
   Web of Science ®Google Scholar
• Shaw SY, Nugent Z, Targownik LE, et al. Association between spring season of birth and Crohn’s disease. Clin Gastroenterol Hepatol. 2014;12:277–282.
   PubMed Web of Science ®Google Scholar
• Niu J, Miao J, Tang Y, et al. Identification of environmental factors associated with inflammatory bowel disease in a southwestern highland region of China: a nested case-control study. PLoS One. 2016;11:e0153524.
   PubMed Web of Science ®Google Scholar
• Fanaro S, Chierici R, Guerrini P, et al. Intestinal microflora in early infancy: composition and development. Acta Paediatr Suppl. 2003;91:48–55.
   PubMedGoogle Scholar
• Sullivan Å, Edlund C, Nord CE. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis. 2001;1:101–114.
   PubMedGoogle Scholar
• Knoop KA, McDonald KG, Kulkarni DH, et al. Antibiotics promote inflammation through the translocation of native commensal colonic bacteria. Gut. 2016;65:1100–1109.
   PubMed Web of Science ®Google Scholar
• Brestoff JR, Artis D. Commensal bacteria at the interface of host metabolism and the immune system. Nat Immunol. 2013;14:676–684.
   PubMed Web of Science ®Google Scholar
• Hill DA, Artis D. Intestinal bacteria and the regulation of immune cell homeostasis. Annu Rev Immunol. 2010;28:623–667.
   PubMed Web of Science ®Google Scholar
• Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9:313–323.
   PubMed Web of Science ®Google Scholar
• Guarner F, Bourdet-Sicard R, Brandtzaeg P, et al. Mechanisms of disease: the hygiene hypothesis revisited. Nat Rev Gastroenterol Hepatol. 2006;3:275–284.
   Web of Science ®Google Scholar
• Liu JZ, van Sommeren S, Huang H, et al. International Multiple Sclerosis Genetics Consortium, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015;47:979–986.
   PubMed Web of Science ®Google Scholar
• Mak WY, Zhao M, Ng SC, et al. The epidemiology of inflammatory bowel disease: east meets west. J Gastroenterol Hepatol. 2019. DOI:10.1111/jgh.14872.
   Google Scholar
• Zhao M, Burisch J. Impact of Genes and the Environment on the Pathogenesis and Disease Course of Inflammatory Bowel Disease. Dig Dis Sci. 2019;64:1759–1769.
   PubMed Web of Science ®Google Scholar
• Schwartzbaum J, Ahlbom A, Feychting M. Berkson’s bias reviewed. Eur J Epidemiol. 2002;18:1109–1112.
   Web of Science ®Google Scholar